Mangoceuticals, Inc.
MGRX- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001938046
No open-market purchases or sales by Mangoceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $455.6K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Mangoceuticals, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 8 | 6 | −2 |
| Shares | 328.5K | 483.5K | +155.1K (+47.2%) |
| Value | $72.0K | $147.7K | +$75.7K (+105.1%) |
New holders (2)
Institutions that held Mangoceuticals, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 98,697 | $30.0K | 0.00% |
| PEAK6 Investments LLC | 88,349 | $26.9K | 0.00% |
Sold out (4)
Institutions that held Mangoceuticals, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| McCollum Christoferson Group LLC | 42,700 | $9.26K |
| XTX Topco Ltd | 24,352 | $5.36K |
| Federation des caisses Desjardins du Quebec | 22,000 | $4.77K |
| BFSG, LLC | 200 | $44 |